No abstract

This was a single-site cohort study to evaluate the safety of a new transcervical device (VizAblate™) combining real-time intrauterine sonography with radiofrequency (RF) ablation for the treatment of fibroids. Nineteen women with uterine fibroids received treatment with the VizAblate System in a closed abdomen setting prior to hysterectomy. Twelve of these subjects underwent an immediate abdominal hysterectomy after radiofrequency ablation (acute group), while the remaining seven underwent hysterectomy on post-ablation days 16 and 17 (subacute group). Uteri were sectioned and stained with the viability stain triphenyltetrazolium chloride (TTC) to quantify fibroid ablation dimensions and assess the serosa for thermal injury. Subjects in the subacute group were treated with the VizAblate System under conscious sedation; they provided pain and tolerability data for the interval from ablation through hysterectomy, and indicated overall procedural satisfaction. Twenty-two ablations ranging from 1.8 to 36.2 cm 3 were created among 19 subjects within 20 fibroids and one region of adenomyosis. There were no complications or thermal serosal injury. For subjects in the subacute group receiving one ablation, the mean total procedure time was 25.8±6.0 min (range 18-32 min). All subjects in the subacute group were discharged within 2 h of the VizAblate procedure. For fibroids≤5 cm, 67.2%± 27.0% of the fibroid volume was ablated (range 15-100%; median 75%). Transcervical RF ablation of fibroids under intrauterine sonographic guidance with the VizAblate system can be accomplished with a high degree of reliability and without adverse events.

No abstract

Case presentation25-year-old patient, G2C1A1. FUM 05/15/2022, so-so. Two months before, she performed transvaginal post-abortion ultrasound (USG), finding a 6x6cm right adnexal tumor; Referred for new assessment, USG reporting a 9.5x7cm tumor, which is why she went to the University Hospital, accompanied by colicky pain in the right lower quadrant, in a scale of pain 6/10. Physical exam: normal vital signs. Abdomen with right adnexal tumor of 7x5cm, mobile, painless. Vulva and vagina normal; cervix closed, mobile, not painful; uterus in AVF indirect hysterometry of 8cm.

No abstract